118 filings
8-K
Valeritas Holdings Inc.
2 Apr 20
Entry into a Material Definitive Agreement
5:08pm
8-K
Valeritas Holdings Inc.
20 Mar 20
Valeritas Receives Court Approval of Sale of Business to Zealand Pharma
4:49pm
8-K
Valeritas Holdings Inc.
18 Mar 20
Entry into a Material Definitive Agreement
4:46pm
8-K
Valeritas Holdings Inc.
16 Mar 20
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
4:37pm
8-K
Valeritas Holdings Inc.
28 Feb 20
Departure of Directors or Certain Officers
4:10pm
8-K
etge9dmmyvm2ommrb9
14 Feb 20
Entry into a Material Definitive Agreement
12:00am
8-K
ehe0phm aaam9
10 Feb 20
Valeritas Announces Agreement for Zealand Pharma to Acquire Business and Retain Employees
6:03am
8-K
5zlcbr7
10 Jan 20
Departure of Directors or Certain Officers
4:02pm
8-K
qs0g016ctr
23 Dec 19
Departure of Directors or Certain Officers
8:59am
8-K
yfssisryvs
20 Dec 19
Valeritas Experiences a Temporary Supply Disruption Resulting in Revised Preliminary Financial Results for 2019 Fourth Quarter and Full Year
4:45pm
8-K
pzo7an37sx 68uv2p6
11 Dec 19
Other Events
5:13pm
8-K
hl7lfvbc22l8y
9 Dec 19
Valeritas Presents Positive h-Patchâ„¢ CBD Study Data as a Late-Breaking Presentation at the American Epilepsy Society 2019 Annual Meeting
5:03pm
8-K
neiciy6ufnt1vaj
20 Nov 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:02pm
8-K
z842n hv2x3
15 Nov 19
Other Events
4:03pm
8-K
qd5q n30ccy7oignz
12 Nov 19
Valeritas Announces Third Quarter 2019 Financial Results
4:11pm
8-K
kmvrif19
21 Oct 19
Other Events
4:35pm
8-K
uj9n0r66n8uu7 xnzcwx
2 Oct 19
Valeritas Reduces its Long-Term Debt Obligation Nearly 60% by Exchanging $25.0 Million of Debt for Series B Convertible Preferred Stock
7:07am
8-K
cdlb7r
20 Sep 19
Other Events
9:28pm
8-K
xaj55 9c4i
13 Sep 19
Other Events
7:16am
8-K
g5exbkymd6acniw
12 Sep 19
Valeritas Presents Positive CBD h-Patchâ„¢ Data at the 2nd Annual International Cannabinoid-Derived Pharmaceuticals Summit
4:47pm